Dr. Srikala Meda, MD
What this data tells you about Dr. Meda
Dr. Srikala Meda is an internal medicine specialist in Midland, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Meda performed 6,967 Medicare services across 957 unique beneficiaries.
Between the years covered by Open Payments, Dr. Meda received a total of $1,931 from 23 pharmaceutical and/or device companies across 43 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Meda is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) | 2,100 | $0 | $5 |
| Dexamethasone injection (steroid) | 1,486 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 410 | $0 | $24 |
| Injection, iron dextran, 50 mg | 402 | $13 | $42 |
| Anti-nausea injection (Aloxi/palonosetron) | 350 | $1 | $114 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 250 | $22 | $157 |
| Blood draw (venipuncture) | 201 | $8 | $20 |
| Complete blood count (CBC) with differential | 201 | $8 | $36 |
| Comprehensive metabolic blood panel | 174 | $10 | $64 |
| Administration of chemotherapy into vein, 1 hour or less | 162 | $98 | $707 |
| Office visit, established patient (30-39 min) | 91 | $95 | $368 |
| Irrigation of implanted venous access drug delivery device | 85 | $18 | $114 |
| Administration of chemotherapy into vein, each additional hour | 80 | $21 | $161 |
| Drug injection, under skin or into muscle | 77 | $11 | $96 |
| Injection, zoledronic acid, 1 mg | 77 | $7 | $431 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 72 | $46 | $313 |
| Injection, diphenhydramine hcl, up to 50 mg | 72 | $1 | $7 |
| Injection of additional new drug or substance into vein | 63 | $12 | $108 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 55 | $15 | $100 |
| Office visit, established patient, complex (40-54 min) | 49 | $129 | $496 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 48 | $139 | $3,675 |
| Magnesium level test | 46 | $7 | $29 |
| Ferritin level test (iron stores) | 42 | $13 | $60 |
| Iron level test | 42 | $6 | $27 |
| Iron binding capacity test | 42 | $8 | $35 |
| New patient office visit, complex (60-74 min) | 40 | $159 | $709 |
| Unclassified drugs | 39 | $1 | $8 |
| Administration of additional new drug or substance into vein, 1 hour or less | 37 | $48 | $344 |
| Infusion into a vein for hydration, each additional hour | 34 | $10 | $75 |
| Reticulated (young) platelet measurement | 32 | $35 | $143 |
| Infusion, normal saline solution , 1000 cc | 32 | $2 | $19 |
| Infusion into a vein for hydration, 31-60 minutes | 23 | $25 | $256 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $24 | $145 |
| Drawing of blood for a medical problem | 19 | $56 | $264 |
| Injection of drug or substance into vein | 14 | $26 | $247 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Meda is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Meda experienced with anti-nausea injection (fosaprepitant)?
Does Dr. Meda receive payments from pharmaceutical companies?
How do Dr. Meda's costs compare to other internal medicine physicians in Midland?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology